| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.049 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |